oral antidiabetic drug(English)
- the combination add-on therapy of insulin glargine, on metformin and DPP-4 inhibitors with or without SU appears safe and efficient in reducing HbA1c levels and thus, is a preferable option in managing T2DM patients exhibiting dysglycemia despite the use of OADs
- DPP-4, T2DM, HbA1C, SU, BG, BID, MET, TID
- Diabetes, Therapeutic approaches, Insulin, Metabolism
- https://doi.org…3/dmj.2018.0092
- https://doi.org…era.2007.11.017